Norgestrel, a progesterone analogue, promotes significant long-term neuroprotection of cone photoreceptors in a mouse model of retinal disease

Loading...
Thumbnail Image
Files
i1552-5783-60-8-3221 (1).pdf(2.83 MB)
Published version
iovs-60-08-27_s01.pdf(283.96 KB)
Supplementary file 1
iovs-60-08-27_s02.pdf(165.79 KB)
Supplementary file 2
Date
2019-07-25
Authors
Roche, Sarah L.
Kutsyr, Oksana
Cuenca, Nicolás
Cotter, Thomas G.
Journal Title
Journal ISSN
Volume Title
Publisher
Association for Research in Vision and Ophthalmology
Published Version
Research Projects
Organizational Units
Journal Issue
Abstract
Purpose: Retinitis pigmentosa (RP) refers to a group of inherited blinding retinal diseases, whereby the death of mutated rod photoreceptors is followed closely by the death of cone photoreceptors. Cone cell death can be hugely debilitating as color/daytime vision becomes impaired. Thus, treatments that are effective against cone cell death are urgently needed. Our research has been working toward development of a neuroprotective treatment for RP. We have previously demonstrated significant neuroprotective properties of norgestrel, a progesterone analogue, in the mouse retina. The current study further investigates the potential of norgestrel as a treatment for RP, with a focus on long-term preservation of cone photoreceptors. Methods: Using the well-established rd10 mouse model of RP, we administered a norgestrel-supplemented diet at postnatal day (P)30, following widespread loss of rod photoreceptors and at the outset of cone degeneration. We subsequently assessed cone cell morphology and retinal function at P50, P60, and P80, using immunohistochemistry, electroretinograph recordings, and optomotor testing. Results: While cone cell degeneration was widespread in the untreated rd10 retina, we observed profound preservation of cone photoreceptor morphology in the norgestrel-treated mice for at least 50 days, out to P80. This was demonstrated by up to 28-fold more cone arrestin-positive photoreceptors. This protection transpired to functional preservation at all ages. Conclusions: This work presents norgestrel as an incredibly promising long-term neuroprotective compound for the treatment of RP. Crucially, norgestrel could be used in the mid-late stages of the disease to protect remaining cone cells and help preserve color/daytime vision.
Description
Keywords
Retinitis pigmentosa , Cone photoreceptors , Neuroprotection , Progesterone , Rd10
Citation
Roche, S. L., Kutsyr, O., Cuenca, N. and Cotter, T. G. (2019) 'Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease', Investigative Ophthalmology & Visual Science, 60(8), pp. 3221-3235. (14pp.) DOI: 10.1167/iovs.19-27246